Dr. Cognetta is one of the nation’s leading dermatologists with the largest skin cancer practice in Florida. He is the Assoc. Professor Dermatology at FSU and Clinical Professor and Chief of the Division of Dermatology for FSU. He has supported many FDA drug approval submissions to treat skin cancers and is leading Phase I/II trials for squamous cell cancer, basal cell cancer, actinic keratosis, and sebhorreic keratosis, in a 24 million patient pool.
Current role
Scientific Advisor And Co-founder at Transformative
Managing Partner & Senior Scientific Advisor at Brookline Capital Markets
Chair of the Scientific Advisory Board at Therini Bio, Inc.
Scientific Advisor at zPREDICTA
Co-Founder and Scientific Advisor at Amorphology, Inc
Access the worlds's biggest network of public org charts
Learn more